✦ LIBER ✦

Escalated-dose Conformai Radiotherapy for Localised Prostate Cancer: Long-term Overall Survival Results From the MRC RT01 Randomised Controlled Trial

✍ Scribed by D.P. Dearnaley; G. Jovic; I. Syndikus; J.D. Graham; E.G. Aird; V. Khoo; R. Cowan; M.R. Sydes

Book ID: 117660619
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 63 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(11)70120-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Escalated-dose versus control-dose confo

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

✍ Dearnaley, David P; Jovic, Gordana; Syndikus, Isabel; Khoo, Vincent; Cowan, Rich 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 385 KB

Escalated-dose versus standard-dose conf

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

✍ David P Dearnaley; Matthew R Sydes; John D Graham; Edwin G Aird; David Bottomley 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 420 KB

The early toxicity of escalated versus s

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

✍ David P. Dearnaley; Matthew R. Sydes; Ruth E. Langley; John D. Graham; Robert A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 536 KB

Adjuvant therapy with oral sodium clodro

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials

✍ David P Dearnaley; Malcolm D Mason; Mahesh KB Parmar; Karen Sanders; Matthew R S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 192 KB

Evaluating the relationship between erec

Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: Using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)

✍ Stephen A. Mangar; Matthew R. Sydes; Helen L. Tucker; Jerome Coffey; Syed A. Soh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 199 KB

MP53-20 THE PREDICTIVE VALUE OF 2-YEAR P

MP53-20 THE PREDICTIVE VALUE OF 2-YEAR POST-TREATMENT BIOPSY AFTER PROSTATE CANCER CONFORMAL RADIOTHERAPY FOR FUTURE OVERALL SURVIVAL AND BIOCHEMICAL FAILURE. THE RESULTS OF THE UK MRC RT01 TRIAL.

✍ Kass-iliyya, Antoine; Jovic, Gordana; Sydes, Matthew; Fisher, Cyril; Murphy, Cla 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 328 KB